文献速递泌尿生殖腹部MR

COVID-19对前列腺MRI和引导活检操作的影响及附带损害:腹部放射学会前列腺癌疾病聚焦小组调查分析

The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis.
PubMed 文献 · Abdom Radiol (NY) · 2021-04-27

该调查通过Qualtrics问卷收集全球五大洲60份完整回复,评估COVID-19大流行对前列腺MRI检查和活检操作的影响。结果显示封锁期间前列腺MRI周中位数从20例降至10例,活检从4.5例降至0例,47%机构面临人员中断,68%报告门诊日程变化,多达50%机构的前列腺MRI/活检研究受影响。

要点

  • 封锁期间前列腺MRI和活检量显著下降,活检中位数降至0例。
  • 近半数机构放射科人员中断,多数机构相关临床科室日程改变。
  • 多达50%机构的前列腺MRI/活检研究受到疫情影响。

诊断标准与关键数值

  • 封锁前前列腺MRI周中位数为20例(范围0-135),封锁期间降至10例(范围0-30)。
  • 封锁前前列腺活检周中位数为4.5例(范围0-60),封锁期间降至0例(范围0-12)。
  • 常规使用肠道准备的30%受访者中,11%因疫情停止肠道准备。
  • 47%报告放射科面临人员中断,68%报告其他临床科室(尤其泌尿外科、泌尿生殖肿瘤内科和放射肿瘤科)日程变化。
  • 多达50%机构的前列腺MRI/活检研究受到影响。

临床应用与阅片要点

  • 在疫情等突发公共卫生事件中,需关注前列腺MRI和活检量的下降及其对前列腺癌诊断延迟的潜在影响。
  • 放射科应制定应急预案以应对人员中断和临床科室日程变化对前列腺MRI操作的影响。

局限性

  • 调查基于自愿参与的问卷,可能存在回应偏倚。
  • 样本量较小(60份完整回复),代表性有限。
  • 仅采用描述性统计,未进行多因素分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The Coronavirus disease 2019 (COVID-19) pandemic has significantly affected health care systems throughout the world. A Qualtrics survey was targeted for radiologists around the world to study its effect on the operations of prostate MRI studies and biopsies. Descriptive statistics were reported. A total of 60 complete responses from five continents were included in the analysis. 70% of the responses were from academic institutions. Among all participants, the median (range) number of prostate MRI was 20 (0, 135) per week before the COVID-19 pandemic versus 10 (0, 30) during the lockdown period; the median (range) number of prostate biopsies was 4.5 (0, 60) per week before the COVID-19 versus 0 (0, 12) during the lockdown period. Among the 30% who used bowel preparation for their patients prior to MRI routinely, 11% stopped the bowel preparation due to the pandemic. 47% reported that their radiology departments faced staff disruptions, while 68% reported changes in clinic schedules in other clinical departments, particularly urology, genitourinary medical oncology, and radiation oncology. Finally, COVID-19 pandemic was found to disrupt not only the clinical prostate MRI operations but also impacted prostate MRI/biopsy research in up to 50% of institutions. The impact of this collateral damage in delaying diagnosis and treatment of prostate cancer is yet to be explored.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Surasi DSS, Wang X, Bathala TK, et al. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis. Abdom Radiol (NY). 2021. PMID: 33904992. doi:10.1007/s00261-021-03087-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。